3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasm Metastasis
9
Colorectal Neoplasms
7
Rectal Neoplasms
5
Colorectal Cancer Metastatic
5
Ovarian Neoplasms
4
Neoplasms
4
Lung Neoplasms
3
Colonic Neoplasms
3
Uveal Melanoma
2
Melanoma
2
Fallopian Tube Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Somatostatinoma
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neurofibromatosis 2
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Macular Degeneration
1
Interventions
Gemcitabine
18
Cisplatin
12
Oxaliplatin
7
pembrolizumab
6
Nivolumab
6
Capecitabine
4
trametinib
3
Fluorouracil
3
Bevacizumab
3
tremelimumab
2
lenvatinib
2
durvalumab
2
derazantinib
2
atezolizumab
2
Trastuzumab
2
Ramucirumab
2
Radiofrequency Ablation
2
Panitumumab
2
Leucovorin
2
Cryosurgery
2
zanidatamab
1
vandetanib
1
tucatinib
1
tocilizumab
1
telotristat ethyl
1
sargramostim
1
rucaparib
1
regorafenib
1
pertuzumab
1
milademetan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Biliary Tract Neoplasms
×
aflibercept
×
Clear all
No trials found.